Modification of cancer biomarkers, such as decreased PCNA and Ki-67, increased Bax/Bcl-2 ratio, increased cleaved caspase-3, decreased VEGF and CD31, and decreased matrix metalloproteinases, especially MMP-2 and MMP-9, were also observed (Table 2, Supplementary Material). The gene discussed is CASP3; the disease is cancer.